Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis

Medicine & Life Sciences

• Adenomyosis 100%
• Matrix Metalloproteinase Inhibitors 86%
• Tissue Inhibitor of Metalloproteinase-1 86%
• Matrix Metalloproteinase 2 79%
• Stromal Cells 72%
• Tissue Inhibitor of Metalloproteinase-2 40%
• Matrix Metalloproteinases 29%
• N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide 16%
• Interleukin-6 15%
• matrigel 12%
• Control Groups 11%
• Endometrium 10%
• Tertiary Care Centers 9%
• University Hospitals 8%
• Health Care Outcome Assessment 6%
• Prospective Studies 6%
• Enzymes 5%
• In Vitro Techniques 4%